Palliative pancreatectomy with postoperative gemcitabine for patients with advanced pancreatic cancer
β Scribed by Yasuhiro Fujino; Tetsuya Sakai; Yoshikazu Kuroda
- Publisher
- Springer Japan
- Year
- 2008
- Tongue
- English
- Weight
- 194 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0944-1174
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Purpose: To evaluate whether celecoxib alters the conversion of gemcitabine into its active metabolite, difluorodeoxycytidine triphosphate (dfdctp), in peripheral blood mononuclear cells (pbmcs). ## Methods: Patients with advanced pancreatic cancer who had not received chemotherapy and had acc
## BACKGROUND. In early phase I1 trials in advanced pancreatic cancer, gemcitabine demonstrated modest antitumor activity. The investigators in these studies reported that gemcitabine should be studied further in view of the degree and frequency of symptomatic improvement observed, the durability o